GMAB logo

Genmab A/S (GMAB) Selling, General & Administrative Expenses

Annual SGA

$478.68 M
+$99.33 M+26.18%

December 31, 2023

Summary

Performance

1-Year Change

+26.18%

3-Year Change

+372.64%

5-Year Change

+1312.08%

15-Year Change

+2039.28%

GMAB SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.28%
GMAB annual SGA is higher than 90.28% of companies in Healthcare sector

High & Low

All-time High

$478.68 M
GMAB annual SGA is currently at an all-time high

3-Year Low

$204.15 M
GMAB annual SGA is currently +134.47% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GMAB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 8, 2025
GMAB next annual earnings announcement is scheduled for May 8, 2025

OtherGMABexpensesmetrics:

Annual Total Expenses

$1.62 B
GMAB annual total expenses is $1.62 billion

Annual Operating Expenses

$1.59 B
GMAB annual total operating expenses is $1.59 billion

Annual Cost Of Goods Sold

$32.81 M
GMAB annual cost of goods sold is $32.81 million

Annual Interest Expense

$3.92 M
GMAB annual interest expense is $3.92 million

Quarterly SGA

$127.48 M
-$1.57 M-1.21%

September 1, 2024

Summary

Performance

3-Month Change

-1.21%

1-Year Change

+1.5%

3-Year Change

+30.76%

5-Year Change

+30.76%

GMAB Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.33%
GMAB quarterly SGA is higher than 89.33% of companies in Healthcare sector

High & Low

All-time High

$134.80 M
GMAB quarterly SGA is currently -5.43% below its historical high of $134.80 million

3-Year Low

$68.19 M
GMAB quarterly SGA is currently +86.96% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABexpensesmetrics:

Quarterly Total Expenses

$504.16 M
GMAB quarterly total expenses is $504.16 million

Quarterly Operating Expenses

$463.93 M
GMAB quarterly total operating expenses is $463.93 million

Quarterly Cost Of Goods Sold

$40.23 M
GMAB quarterly cost of goods sold is $40.23 million

Quarterly Interest Expense

$2.65 M
GMAB quarterly interest expense is $2.65 million

TTM SGA

$11.23 B
+$325.83 M+2.99%

September 1, 2024

Summary

Performance

3-Month Change

+2083.96%

1-Year Change

+2286.79%

3-Year Change

+2670.22%

5-Year Change

+2670.22%

GMAB TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.46%
GMAB TTM SGA is higher than 96.46% of companies in Healthcare sector

High & Low

All-time High

$11.23 B
GMAB TTM SGA is currently at an all-time high

3-Year Low

$5.52 B
GMAB TTM SGA is currently +103.40% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABexpensesmetrics:

Annual Total Expenses

$1.62 B
GMAB annual total expenses is $1.62 billion

Annual Operating Expenses

$1.59 B
GMAB annual total operating expenses is $1.59 billion

TTM Cost Of Goods Sold

$112.79 M
GMAB TTM cost of goods sold is $112.79 million

TTM Interest Expense

$3.24 M
GMAB TTM interest expense is $3.24 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$478.68 M
GMAB annual SGA is $478.68 million

Annual Operating Expenses

$1.59 B
GMAB annual total operating expenses is $1.59 billion

Annual Cost Of Goods Sold

$32.81 M
GMAB annual cost of goods sold is $32.81 million

GMAB Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.2%+1.5%+2286.8%
3 y3 years+372.6%+30.8%+2670.2%
5 y5 years+1312.1%+30.8%+2670.2%

GMAB Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+134.5%-5.4%+87.0%at high+103.4%
5 y5-yearat high+833.5%-5.4%+714.6%at high+2710.2%
alltimeall timeat high+7558.3%-5.4%+4824.0%at high+387.7%

Genmab A/S Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$127.48 M(-1.2%)
$516.15 M(+0.4%)
Jun 2024
-
$129.04 M(+3.4%)
$514.26 M(+1.6%)
Mar 2024
-
$124.83 M(-7.4%)
$506.08 M(+5.7%)
Dec 2023
$478.68 M(+26.2%)
$134.80 M(+7.3%)
$478.74 M(+1.7%)
Sep 2023
-
$125.59 M(+3.9%)
$470.56 M(+8.0%)
Jun 2023
-
$120.87 M(+24.0%)
$435.67 M(+7.5%)
Mar 2023
-
$97.49 M(-23.0%)
$405.43 M(+7.8%)
Dec 2022
$379.35 M(+85.8%)
$126.61 M(+39.6%)
$376.12 M(+14.6%)
Sep 2022
-
$90.71 M(+0.1%)
$328.26 M(+14.7%)
Jun 2022
-
$90.62 M(+32.9%)
$286.07 M(+20.1%)
Mar 2022
-
$68.19 M(-13.4%)
$238.23 M(+17.6%)
Dec 2021
$204.15 M(+101.6%)
$78.75 M(+62.3%)
$202.63 M(+25.9%)
Sep 2021
-
$48.51 M(+13.4%)
$160.88 M(+19.0%)
Jun 2021
-
$42.78 M(+31.3%)
$135.15 M(+13.8%)
Mar 2021
-
$32.58 M(-11.9%)
$118.80 M(+16.6%)
Dec 2020
$101.28 M(+97.5%)
$37.00 M(+62.4%)
$101.87 M(+24.1%)
Sep 2020
-
$22.78 M(-13.8%)
$82.06 M(+15.0%)
Jun 2020
-
$26.43 M(+68.9%)
$71.35 M(+27.6%)
Mar 2020
-
$15.65 M(-9.0%)
$55.89 M(+9.5%)
Dec 2019
$51.28 M(+51.3%)
$17.20 M(+42.5%)
$51.05 M(+19.2%)
Sep 2019
-
$12.07 M(+9.9%)
$42.82 M(+8.8%)
Jun 2019
-
$10.98 M(+1.6%)
$39.36 M(+5.5%)
Mar 2019
-
$10.81 M(+20.5%)
$37.31 M(+10.3%)
Dec 2018
$33.90 M(+51.5%)
$8.97 M(+4.2%)
$33.83 M(+8.7%)
Sep 2018
-
$8.61 M(-3.7%)
$31.13 M(+9.5%)
Jun 2018
-
$8.93 M(+21.9%)
$28.44 M(+15.0%)
Mar 2018
-
$7.33 M(+16.9%)
$24.73 M(+10.6%)
Dec 2017
$22.38 M(+47.0%)
$6.27 M(+6.1%)
$22.37 M(+14.3%)
Sep 2017
-
$5.91 M(+13.0%)
$19.57 M(+10.3%)
Jun 2017
-
$5.23 M(+5.4%)
$17.74 M(+9.3%)
Mar 2017
-
$4.96 M(+43.0%)
$16.24 M(+6.6%)
Dec 2016
$15.22 M(+12.2%)
$3.47 M(-15.0%)
$15.23 M(+1.1%)
Sep 2016
-
$4.08 M(+9.6%)
$15.06 M(+7.2%)
Jun 2016
-
$3.73 M(-5.7%)
$14.04 M(+1.7%)
Mar 2016
-
$3.95 M(+19.7%)
$13.81 M(+1.7%)
DateAnnualQuarterlyTTM
Dec 2015
$13.57 M(-4.3%)
$3.30 M(+7.5%)
$13.58 M(-3.8%)
Sep 2015
-
$3.07 M(-12.2%)
$14.11 M(-2.8%)
Jun 2015
-
$3.50 M(-5.9%)
$14.51 M(+0.2%)
Mar 2015
-
$3.71 M(-3.0%)
$14.48 M(+2.5%)
Dec 2014
$14.18 M(+19.4%)
$3.83 M(+10.4%)
$14.13 M(+1.2%)
Sep 2014
-
$3.47 M(+0.0%)
$13.96 M(+6.7%)
Jun 2014
-
$3.47 M(+3.2%)
$13.08 M(+4.5%)
Mar 2014
-
$3.36 M(-8.1%)
$12.51 M(+5.1%)
Dec 2013
$11.88 M(+6.5%)
$3.66 M(+41.3%)
$11.90 M(+5.7%)
Sep 2013
-
$2.59 M(-10.8%)
$11.26 M(-0.7%)
Jun 2013
-
$2.90 M(+5.3%)
$11.35 M(+0.9%)
Mar 2013
-
$2.75 M(-8.8%)
$11.25 M(+0.8%)
Dec 2012
$11.16 M(-12.0%)
$3.02 M(+12.9%)
$11.16 M(+2.4%)
Sep 2012
-
$2.67 M(-4.6%)
$10.89 M(-5.6%)
Jun 2012
-
$2.80 M(+5.2%)
$11.54 M(-5.2%)
Mar 2012
-
$2.66 M(-3.3%)
$12.16 M(-4.1%)
Dec 2011
$12.67 M(-55.6%)
$2.75 M(-17.0%)
$12.69 M(-17.7%)
Sep 2011
-
$3.32 M(-3.2%)
$15.42 M(-7.9%)
Jun 2011
-
$3.43 M(+7.6%)
$16.74 M(-34.0%)
Mar 2011
-
$3.19 M(-41.9%)
$25.36 M(-10.3%)
Dec 2010
$28.53 M(+2.5%)
$5.48 M(+18.2%)
$28.28 M(-4.2%)
Sep 2010
-
$4.64 M(-61.5%)
$29.50 M(-9.5%)
Jun 2010
-
$12.05 M(+97.5%)
$32.61 M(+21.5%)
Mar 2010
-
$6.10 M(-9.0%)
$26.85 M(-3.4%)
Dec 2009
$27.84 M(-1.5%)
$6.71 M(-13.4%)
$27.80 M(+31.8%)
Sep 2009
-
$7.75 M(+23.2%)
$21.09 M(+58.1%)
Jun 2009
-
$6.29 M(-10.8%)
$13.34 M(+89.2%)
Mar 2009
-
$7.05 M
$7.05 M
Dec 2008
$28.27 M(+30.9%)
-
-
Dec 2007
$21.60 M(+245.6%)
-
-
Dec 2006
$6.25 M(-1.6%)
-
-
Dec 2005
$6.35 M(-47.3%)
-
-
Dec 2004
$12.05 M(+22.6%)
-
-
Dec 2003
$9.83 M(-11.1%)
-
-
Dec 2002
$11.05 M
-
-

FAQ

  • What is Genmab A/S annual SGA?
  • What is the all time high annual SGA for Genmab A/S?
  • What is Genmab A/S annual SGA year-on-year change?
  • What is Genmab A/S quarterly SGA?
  • What is the all time high quarterly SGA for Genmab A/S?
  • What is Genmab A/S quarterly SGA year-on-year change?
  • What is Genmab A/S TTM SGA?
  • What is the all time high TTM SGA for Genmab A/S?
  • What is Genmab A/S TTM SGA year-on-year change?

What is Genmab A/S annual SGA?

The current annual SGA of GMAB is $478.68 M

What is the all time high annual SGA for Genmab A/S?

Genmab A/S all-time high annual SGA is $478.68 M

What is Genmab A/S annual SGA year-on-year change?

Over the past year, GMAB annual SGA has changed by +$99.33 M (+26.18%)

What is Genmab A/S quarterly SGA?

The current quarterly SGA of GMAB is $127.48 M

What is the all time high quarterly SGA for Genmab A/S?

Genmab A/S all-time high quarterly SGA is $134.80 M

What is Genmab A/S quarterly SGA year-on-year change?

Over the past year, GMAB quarterly SGA has changed by +$1.89 M (+1.50%)

What is Genmab A/S TTM SGA?

The current TTM SGA of GMAB is $11.23 B

What is the all time high TTM SGA for Genmab A/S?

Genmab A/S all-time high TTM SGA is $11.23 B

What is Genmab A/S TTM SGA year-on-year change?

Over the past year, GMAB TTM SGA has changed by +$10.76 B (+2286.79%)